Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Diagram of displacement variation. by Yifei Li (198040)

Subjects:

Scheme and results of orthogonal test. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

The millet mode. by Yifei Li (198040)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…Each map represents a 3-dimensional view of statistically affected voxels (p < 0.05), where the red scale indicates a decrease in plaque count, and the cyan scale represents an increase. …”

Technical properties of tested UASs. by Marc Roswag (20598443)

“…Our results support this hypothesis, because multicopter flights have a highly significant negative impact on bat activity levels with a medium effect size, particularly for the Myotini (<i>P</i> < 0.001, <i>d</i>_<i>m</i> = 0.54) and Nyctaloid group (<i>P</i> < 0.001, <i>d</i>_<i>n</i> = 0.55) and a small effect size for the Pipistrelloid group (<i>P</i> < 0.001, <i>d</i>_<i>p</i> = 0.36). …”

Flowchart of the study. by Flavia Furlaneto (20161022)

“…<i>Granulicatella adiacens</i> decreased significantly after the probiotic therapy, while <i>Saccharibacteria</i> (TM7) spp., <i>Solobacterium moorei</i>, and <i>Catonella morbi</i> increased significantly. …”

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

(A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 t... by Aman Goyal (19231397)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Estimated marginal mean values representative of the average time on ball and the relative frequency of ball touches and releases per minute of match duration, performed by profess... by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”

Estimated marginal mean (± SE) age group differences in the average time on ball performed by professional soccer players on a match day for each position. by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”

Estimated marginal mean values representative of the inter-positional differences in average time on ball and the relative frequency of ball touches and releases per minute of matc... by Emily Escreet (20552634)

Subjects: “…tailed statistical significance…”